17335-88-5

Basic information

• Product Name: Glycine, N-(carboxymethyl)-N-[(phenylmethoxy)carbonyl]-
• CAS NO: 17335-88-5
• Molecular Formula: C12H13NO6
• Molecular Weight: 267.238
• Mol File: 17335-88-5.mol
• Article Data: 15

Chemical Properties

• CAS DataBase Reference: Glycine, N-(carboxymethyl)-N-[(phenylmethoxy)carbonyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Glycine, N-(carboxymethyl)-N-[(phenylmethoxy)carbonyl]-(17335-88-5)
• EPA Substance Registry System: Glycine, N-(carboxymethyl)-N-[(phenylmethoxy)carbonyl]-(17335-88-5)

Safety Data

• Hazardous Substances Data: 17335-88-5(Hazardous Substances Data)

Upstream product

• 501-53-1 benzyl chloroformate 
• 76698-56-1 N-benzyloxycarbonyliminodiacetic acid dicyclohexylamine salt 
• 77-92-9 citric acid 
• 142-73-4 iminodiacetic acid 

Downstream Products

• 105400-47-3 (benzyloxycarbonyl)bis<<(pentafluorophenoxy)carbonyl>methyl>amine 
• 126765-07-9 [Benzyloxycarbonyl-(2,5-dioxo-pyrrolidin-1-yloxycarbonylmethyl)-amino]-acetic acid 2,5-dioxo-pyrrolidin-1-yl ester 
• 1443662-67-6 bis(pivaloyloxymethyl)-N-benzyloxycarbonyl iminodiacetate 

Relevant articles and documents

Synthesis and binding properties of hybrid cyclophane - Azamacrocyclic receptors

(Chemical Equation Presented). Three new azamacrocyclic-cyclophane hybrid receptors L1, L2, and L3 have been synthesized that incorporate either 1,4,7,10-tetraazacyclododecane (cyclen) or 1,4,7-triazacyclononane (tacn) uni

Substance related with tophatib and preparation method and application thereof

The invention discloses a substance related with tophatib and a preparation method and application thereof. The substance is named as N,N'-diacetyl{(3R,4R)-4-methyl-3-[methyl(7H-pyrrole[2,3-D]pyrimidine-4-yl)amine]piperidine-1-yl}imine. The impurity is characterized in that the generation level is lower in the condensation reaction process; however, the impurity has the uniform main functional groups with the tophatib, the cleaning effect is limited in the subsequent salting and refining process, and the influence to the qualities of crude drug and finished product of tophatib is larger; by detecting the existence of the impurity, the qualities of the raw material and preparation of the tophatib can be effectively determined.

TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS

The present invention is directed to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents A, R1, R2, R3a, R3b, R4a, R4b and n are as defined herei